Lab Automation Market Emerging Trend, Growth, Revenue by 2032 | Fact.MR

Comments · 56 Views

From 2015 to 2021, the global lab automation market expanded at a CAGR of 6.1%. The clinical lab automation segment accounts for the vast majority of the global lab automation market.

Demand for lab automation services increased by more than 11% year on year in 2022 compared to 2021, rising from US$ 1.8 billion to US$ 2 billion. Going forward, the market is expected to grow at a 7% value CAGR from 2022 to 2032, reaching a valuation of nearly US$ 4 billion.

From 2015 to 2021, the global lab automation market expanded at a CAGR of 6.1%. The clinical lab automation segment accounts for the vast majority of the global lab automation market. Factors such as an aging population with rising healthcare costs, an increase in the prevalence of infectious diseases, an increase in the number of clinical studies, and advancements in lab automation technologies propelled the growth of the lab automation market during the historical period.

Download FREE Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=Srep_id=5672

Key Segments Covered

Product

Equipment

Automated Workstations

Automated Liquid Handling

Automated Integrated Workstations

Pipetting Systems

Reagent Dispensers

Microplate Washers

Microplate Readers

Multi-mode Microplate Readers

Single-mode Microplate Readers

Automated ELISA Systems

Automated Nucleic Acid Purification  Systems

Software Informatics

Workstation/Unit Automation Software

Laboratory Information Management Systems (LIMS)

Electronic Laboratory Notebook

Scientific Data Management System

Application

Drug Discovery

Clinical Diagnostics

Genomics Solutions

Proteomics Solutions

End User

Biotechnology Pharmaceutical Industries

Research Academic Institutes

Hospitals Diagnostic Laboratories

Forensic Laboratories

Environmental Testing Labs

Food Beverage Industry

Region

North America

Latin America

Europe

Asia Pacific

Middle East Africa

Key Takeaways from Market Study

By product, demand for integrated automated workstations to expand at a rapid pace

Biotechnology pharmaceutical industry experiencing major uptake of lab automation systems

By application, drug discovery and clinical diagnostics to collectively capture a lucrative share

Voluminous biopharmaceuticals manufacturing to elevate lab automation deployment across the U.S.

The U.K. to generate fresh revenue ecosystems amid high reliance on in vitro diagnostics

Growing RD initiatives by government and non-governmental entities bolstering France and Germany’s growth prospects

India and China to emerge as lucrative hotspots amid increasing need to offset asymmetries in efficient lab testing mechanisms

“Growing irregularities in quality diagnosis drug development due to high error margins are prompting healthcare providers to invest in the most contemporary lab automation solutions, driving market growth,”comments a Fact.MR analyst.

Competitive Landscape

Thermo Fisher Scientific, PerkinElmer, Agilent Technologies, Hudson Robotics, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Hamilton Robotics, Bio-Rad Laboratories, bioMerieux SA, Becton Dickinson Company, Qiagen NV, Danaher Corporation, and Hudson Robotics are some prominent lab automation equipment and software providers profiled in Fact.MR’s report.

With regard to solution offerings, Siemens Healthineers provides the SIMATIC SIPAT Process Analytical Technology, facilitating the right-first-time production via Quality by Design (QbD) transfer of previously downstream quality controls into the manufacturing process itself. The software helps healthcare settings become more flexible with regard to production expansion, new product launches, and entry into new markets.

Similarly, Bio-Rad Laboratories offers its CFX Automation System II, a robotic plate handler compatible with all CFX RT-PCR Detection Systems to enable walk-away, high throughput qPCR operation in a simplified format. This systems generates large volumes of data and rapid data analysis. It is ideally suited to meet the high throughput RT-PCR requirements of today’s drug discovery and screening workflows.

Thermo Fisher Scientific

Agilent Technologies

PerkinElmer

Hudson Robotics

Qiagen NV

Hoffmann-La Roche Ltd.

Hamilton Robotics

Siemens Healthineers

Becton Dickinson and Company

Bio-Rad Laboratories

FORMULATRIX

More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the global lab automation market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of product (equipment and software informatics), application (drug discovery, clinical diagnostics, genomic solutions, and proteomics solutions), and end-user (biotechnology pharmaceutical industries, research academic institutes, hospitals diagnostic laboratories, forensic laboratories, environmental testing labs, and food beverage industry), across five major regions of the world.

Comments